These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35402896)

  • 1. Inhaled hydrogel-based microspheres for management of COVID-19: A new sweeper biological platform.
    Cheng R; Santos HA
    Matter; 2022 Apr; 5(4):1065-1067. PubMed ID: 35402896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled ACE2-engineered microfluidic microsphere for intratracheal neutralization of COVID-19 and calming of the cytokine storm.
    Wang Z; Xiang L; Lin F; Cai Z; Ruan H; Wang J; Liang J; Wang F; Lu M; Cui W
    Matter; 2022 Jan; 5(1):336-362. PubMed ID: 34693277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calming the cytokine storm of COVID-19 through inhibition of JAK2/STAT3 signaling.
    Gajjela BK; Zhou MM
    Drug Discov Today; 2022 Feb; 27(2):390-400. PubMed ID: 34743903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.
    Ahmed F
    Front Immunol; 2020; 11():590459. PubMed ID: 33362771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes.
    Karki R; Sharma BR; Tuladhar S; Williams EP; Zalduondo L; Samir P; Zheng M; Sundaram B; Banoth B; Malireddi RKS; Schreiner P; Neale G; Vogel P; Webby R; Jonsson CB; Kanneganti TD
    bioRxiv; 2020 Nov; ():. PubMed ID: 33140051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine storm induced by SARS-CoV-2.
    Song P; Li W; Xie J; Hou Y; You C
    Clin Chim Acta; 2020 Oct; 509():280-287. PubMed ID: 32531256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19.
    Peter AE; Sandeep BV; Rao BG; Kalpana VL
    Front Pharmacol; 2020; 11():583777. PubMed ID: 33708109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm.
    Peng X; Wang Y; Xi X; Jia Y; Tian J; Yu B; Tian J
    Cardiovasc Drugs Ther; 2021 Apr; 35(2):231-247. PubMed ID: 33404925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy Targets SARS-CoV-2 Infection-Induced Cell Death.
    Zhu Z; Shi J; Li L; Wang J; Zhao Y; Ma H
    Front Immunol; 2022; 13():870216. PubMed ID: 35655782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target-Specific Drug Discovery of Natural Products against SARS-CoV-2 Life Cycle and Cytokine Storm in COVID-19.
    Lee M; Park J; Cho IH
    Am J Chin Med; 2022; 50(4):927-959. PubMed ID: 35729089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
    Zhang X; Zhang Y; Qiao W; Zhang J; Qi Z
    Int Immunopharmacol; 2020 Sep; 86():106749. PubMed ID: 32645632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and treatment of cytokine storm in COVID-19.
    Soy M; Keser G; Atagündüz P
    Turk J Biol; 2021; 45(4):372-389. PubMed ID: 34803441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 induces "cytokine storm" hyperinflammatory responses in RA patients through pyroptosis.
    Zheng Q; Lin R; Chen Y; Lv Q; Zhang J; Zhai J; Xu W; Wang W
    Front Immunol; 2022; 13():1058884. PubMed ID: 36532040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies.
    Chong ZZ; Souayah N
    Curr Med Chem; 2022; 29(12):2051-2074. PubMed ID: 33970839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavonoids against the SARS-CoV-2 induced inflammatory storm.
    Liskova A; Samec M; Koklesova L; Samuel SM; Zhai K; Al-Ishaq RK; Abotaleb M; Nosal V; Kajo K; Ashrafizadeh M; Zarrabi A; Brockmueller A; Shakibaei M; Sabaka P; Mozos I; Ullrich D; Prosecky R; La Rocca G; Caprnda M; Büsselberg D; Rodrigo L; Kruzliak P; Kubatka P
    Biomed Pharmacother; 2021 Jun; 138():111430. PubMed ID: 33662680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation, Device, and Clinical Factors Influencing the Targeted Delivery of COVID-19 Vaccines to the Lungs.
    Mossadeq S; Shah R; Shah V; Bagul M
    AAPS PharmSciTech; 2022 Nov; 24(1):2. PubMed ID: 36416999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Copper Iodide Nanoparticle-Doped Film and Fabric To Inactivate SARS-CoV-2 via the Virucidal Activity of Cuprous Ions (Cu
    Takeda Y; Jamsransuren D; Nagao T; Fukui Y; Matsuda S; Ogawa H
    Appl Environ Microbiol; 2021 Nov; 87(24):e0182421. PubMed ID: 34613751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.